ADORE BEAUTY GROUP LIMITED (ABY)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ABY - ADORE BEAUTY GROUP LIMITED

Year End: June
GICS Industry Group : No Sector
Debt/EBITDA: 0.36
Index:

Adore Beauty Group is an Australian online retailer of beauty, skin care and fragrance products. It operates in Australia and New Zealand. It listed on the ASX in 2020.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.015

21 Nov
2024

0.015

OPEN

$0.99

1.50%

HIGH

$1.02

12,955

LOW

$0.99

TARGET
$1.373 35.3% upside
OTHER COMPANIES IN THE SAME SECTOR
AOV . BRG . DSK . MYR . SSG . TRS .
FNARENA'S MARKET CONSENSUS FORECASTS
ABY: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 2.3 4.9 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A 100.0% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 20.4 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 19/05 - (franking Ex-Di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx2.3
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx195.7 M
Book Value Per Share xxxxxxxxxxxxxxx42.2
Net Operating Cash Flow xxxxxxxxxxxxxxx8.3 M
Net Profit Margin xxxxxxxxxxxxxxx1.11 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx5.73 %
Return on Invested Capital xxxxxxxxxxxxxxx5.63 %
Return on Assets xxxxxxxxxxxxxxx3.34 %
Return on Equity xxxxxxxxxxxxxxx5.73 %
Return on Total Capital xxxxxxxxxxxxxxx5.86 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx8.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx2 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx33 M
Price To Book Value xxxxxxxxxxxxxxx2.10

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx3.4 M
Capex % of Sales xxxxxxxxxxxxxxx1.75 %
Cost of Goods Sold xxxxxxxxxxxxxxx154 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx39 M
Research & Development xxxxxxxxxxxxxxx0 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

27/08/2024

3

Neutral

$1.30

28.08%

Adore Beauty's June Q sales were pre-reported, but earnings margins came in at the top-end of the guidance range underpinned by continued cost control, UBS notes. The company continued to highlight subdued consumer sentiment.

There are two risk factors in the broker's view: the CEO departure from October adds uncertainty to strategic direction; and the iKOU acquisition adds execution risk with Adore now extending its business to brand ownership and a physical store presence.

But the iKOU ramp-up lifts earnings forecasts and the broker's target to $1.30 from $1.05. Neutral retained.

FORECAST
UBS forecasts a full year FY25 EPS of 6.00 cents.
UBS forecasts a full year FY26 EPS of 9.00 cents.

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

ABY STOCK CHART